The American Cancer Society National Lung Cancer Roundtable strategic plan: Provider engagement and outreach
Year: 2024
Type: article
Abstract: The American Cancer Society National Lung Cancer Roundtable strategic plan for provider engagement and outreach addresses barriers to the uptake of lung cancer screening, including lack of provider awareness and guideline knowledge about screening, concerns about potential harms from false-positive examinations, lack of time to implement workflows within busy primary care practices, insufficient infrastructure and administrative support to manage a screening program and patient follow-up, and implicit bias based on sex, race/ethnicity, social class, and smoking status. Strategies to facilitate screening include educational programming, clinical reminder systems within the electronic medical record, decision support aids, and tools to track nodules that can be implemented across a diversity of practices and health care organizational structures. PLAIN LANGUAGE SUMMARY: The American Cancer Society National Lung Cancer Roundtable strategic plan to reduce deaths from lung cancer includes strategies designed to support health care professionals, to better understand lung cancer screening, and to support adults who are eligible for lung cancer screening by providing counseling, referral, and follow-up.
Source: Cancer
DOI: 10.1002/cncr.34555
Institutions: Vanderbilt University, Veterans Health Administration, VA Tennessee Valley Healthcare System, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Swedish Medical Center, Drexel University, Memorial Sloan Kettering Cancer Center, University of Colorado Cancer Center, University of Colorado Anschutz, Duke University, Duke Medical Center, American Cancer Society, University of Michigan, Michigan Medicine, The Ohio State University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,740
Funders: U.S. Department of Veterans Affairs, Amgen, Bristol-Myers Squibb, AstraZeneca, Sanofi, Gilead Sciences, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Regeneron Pharmaceuticals, Novocure, Georgia Clinical and Translational Science Alliance, Daiichi-Sankyo, National Institutes of Health, Genentech, Foundation Medicine, National Heart, Lung, and Blood Institute, National Cancer Institute, National Center for Advancing Translational Sciences
OpenAlex ID: W4402678586